Ensi, Mel A.

HRN: 21-82-91  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/23/2022
CEFTRIAXONE 1G (VIAL)
08/23/2022
08/29/2022
IV
1gm
OD
Age With Severe Dehydration
Waiting Final Action 
08/23/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/23/2022
08/30/2022
IV
100mg
Q8
Age With Severe Dehydration
Waiting Final Action 
08/25/2022
MEBENDAZOLE 50MG/ML, 60ML SUSPENSION (BOT)
08/25/2022
08/25/2022
PO
10ml
1 Dose
Ascariasis
08/25/2022
MEBENDAZOLE 50MG/ML, 60ML SUSPENSION (BOT)
08/25/2022
08/27/2022
PO
5ml
BID
Ascariasis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: